Lifevantage (LFVN) Common Equity (2011 - 2026)

Lifevantage's Common Equity history runs 16 years deep, the most recent figure standing at $33.3 million for Q1 2026.

• Quarterly Common Equity fell 1.98% year-over-year to $33.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (down 1.98% YoY) and the FY2025 annual result came in at $34.6 million, up 33.28% from the prior year.
• Common Equity was $33.3 million for Q1 2026 at Lifevantage, up from $33.0 million in the prior quarter.
• Across five years, Common Equity topped out at $34.6 million in Q2 2023 and bottomed at $26.0 million in Q2 2024.
• A 5-year average of $31.3 million and a median of $31.9 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2024 — Common Equity fell 24.99% — and 2025, when it surged 33.28%.
• Lifevantage's Common Equity stood at $31.9 million in 2022, then retreated by 14.38% to $27.3 million in 2023, then advanced by 9.46% to $29.9 million in 2024, then grew by 10.37% to $33.0 million in 2025, then gained by 1.07% to $33.3 million in 2026.
• Business Quant data shows LFVN's Common Equity at $33.3 million in Q1 2026, $33.0 million in Q4 2025, and $33.2 million in Q3 2025.